Spl-deferasirox-chemical-structure (Spl Deferasirox Chemical Structure)
Deferasirox Tablet, For Suspension
Product Images NDC 62756-570
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 5 technical images submitted to the FDA as part of the official labeling for Deferasirox (NDC 62756-570). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Sun Pharmaceutical Industries, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Spl-deferasirox-figure-1 (Spl Deferasirox Figure 1)
This appears to be a table that shows the change in liver iron content and serum ferritin levels based on the dosage of Deferasirox tablets in milligrams per kilogram per day. The number of participants and the corresponding measurements is provided. There is not enough information to determine the purpose or context of the study.*
Spl-deferasirox-label-125mg (Spl Deferasirox Label 125mg)
This text provides instructions and a warning for the medication Deferasirox Tablets for Oral Suspension. The tablets cannot be chewed or swallowed whole, and must be dispersed in water or juice prior to ingestion. It also includes a note to pharmacists to dispense with a medication guide to each patient. The text includes a product identifier (NDC 62756-568-83) and some codes or references (DNHDRUGS/NH/138 and PGLB13428).*
Spl-deferasirox-label-250mg (Spl Deferasirox Label 250mg)
This is a description of Deferasirox Tablets medication. Each uncoated tablet contains 250 mg of the medication. It is usually taken orally and should not be chewed or swallowed whole. The dosage and other necessary information can be found in the prescribing information and the medication guide. The tablets must be dispersed in water, orange, or apple juice prior to ingestion. The medication should be stored at a temperature of 20° to 25°C (68 to 77°F), and should be protected from moisture. The medication should be kept out of the reach of children. The medication is manufactured by Sun Pharmaceutical Industries Ltd and distributed by Sun Pharmaceutical Industries, Inc.*
Spl-deferasirox-label-500mg (Spl Deferasirox Label 500mg)
Each tablet contains 500 mg of deferasirox, an oral medication used to treat chronic iron overload. Deferasirox needs to be dispersed in water, orange, or apple juice before ingestion, and it should not be chewed or swallowed whole. The medication guide is available online. It is crucial to store deferasirox at the right temperature and protect it from moisture. The recommended temperature is 20-25°C, and excursions are allowed between 15-30°C. Medication Guide should be dispensed to each patient along with the prescription. If you have children, it is essential to keep this and all medication out of their reach. The manufacturer is Sun Pharmaceutical, and the product's NDC is 62756-570-83.*
* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.
